January 27, 2026 (MLN):  Haleon Pakistan Limited (PSX:HALEON) is to invest £3.58 million in the expansion and modernization of its Panadol Liquid packaging line.

The strategic investment focuses on enhancing production capacity, improving operational efficiency, and meeting growing market demand for Panadol Liquid products.

The Board of Directors of Haleon Pakistan Limited has approved both the investment and its associated financing, according to the company's statement issued today.

The expansion project encompasses procurement of advanced packaging machinery, upgrades to existing infrastructure, and implementation of quality control enhancements.

These improvements are designed to strengthen the company's manufacturing capabilities and ensure product quality standards.

The initiative emphasizes Haleon Pakistan's commitment to innovation and its long-term growth strategy in the consumer healthcare segment.

The modernization of the Panadol Liquid packaging line represents a significant step in the company's efforts to maintain its competitive position in Pakistan's pharmaceutical market.

Copyright